NCT04254458

Brief Summary

Purpose: Our purpose was to investigate the laser peripheral iridotomy (LPI) induced changes in corneal densitometry in acute primary angle closure glaucoma (PACG) cases during the post-laser 1 month period. Material and methods: This prospective study included 21 eyes of 21 cases with first acute attack of PACG. All the eyes underwent LPI with neodymium: yttrium-aluminum-garnet (Nd: YAG) laser after the intraocular pressure (IOP) decreased to normal levels with maximal systemic and topical anti-glaucoma treatment and complete regression of clinically significant corneal edema. Central corneal thickness (CCT) and corneal density values were measured by densitometry software of Pentacam HR-Scheimpflug corneal topography over a 12-mm diameter of the cornea just before LPI and at the first week and the first month after LPI. Kolmogorov smirnov and paired-t tests were used for statistical analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 22, 2018

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2019

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
Last Updated

February 5, 2020

Status Verified

January 1, 2020

Enrollment Period

1.4 years

First QC Date

January 29, 2020

Last Update Submit

February 3, 2020

Conditions

Keywords

Cornea,density,laser peripheral iridotomy,primary angle closure glaucoma

Outcome Measures

Primary Outcomes (1)

  • Measurement of corneal density by Pentacam HR-Scheimpflug corneal topography

    The measurements were done between 9 am and 2 pm under standard dim-light conditions without pupil dilatation. The CD values of anterior layer (anterior 120 µm), central (between anterior layer and posterior 60 µm), posterior layer (posterior 60 µm) of 4 annular concentric zones as 0-2 mm zone, 2-6 mm zone, 6-10 mm zone and 10-12 mm zone were measured. The CD values were expressed in grayscale units (GSC) as 0 for maximum transparency and 100 for total corneal opacity. Measurement were done just before laser treatment and repeated at the first week and month.

    1 month

Secondary Outcomes (1)

  • Measurement of central corneal thickness by Pentacam HR-Scheimpflug corneal topography

    1 month

Study Arms (1)

PACG group

Cases who had first acute attack of primary angle closure glaucoma

Diagnostic Test: Corneal densitometry

Interventions

Corneal densitometryDIAGNOSTIC_TEST

Corneal density values were measured by densitometry software of Pentacam HR-Scheimpflug corneal topography

PACG group

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients were Turkish Caucasians with with first attack of primary angle closure glaucoma

You may qualify if:

  • Acute primary angle closure glaucoma cases with first attack
  • high IOP (\>40 mmHg)
  • corneal edema
  • red eye
  • mid-dilated pupil
  • presence of the symptoms like blurred vision, halos, ocular pain, headache, nausea and vomiting

You may not qualify if:

  • The cases who had histories of any types of glaucoma or increased IOP before
  • any corneal diseases like keratokonus
  • corneal opacity
  • dry eye or any ocular surface diseases
  • ocular surgery or laser treatment
  • trauma
  • uveitis or other inflammation and contact lens use and diabetic cases were excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ufuk Elgin

Ankara, Altindag, 06240, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Corneal DiseasesGlaucoma, Angle-Closure

Condition Hierarchy (Ancestors)

Eye DiseasesGlaucomaOcular Hypertension

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 29, 2020

First Posted

February 5, 2020

Study Start

March 22, 2018

Primary Completion

August 20, 2019

Study Completion

September 1, 2019

Last Updated

February 5, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations